Eli Lilly Scraps Major Cholesterol-Inhibitor Drug; Shares Fall 7.7%
October 12, 2015 at 19:30 PM EDT
Eli Lilly announces the discontinuation of its drug evacetrapib used to treat patients with high levels of bad cholesterol
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
